Preparation and in vivo evaluation of SMEDDS (self-microemulsifying drug delivery system) containing fenofibrate
about
Role of Components in the Formation of Self-microemulsifying Drug Delivery SystemsPreparation and characterization of fenofibrate-loaded nanostructured lipid carriers for oral bioavailability enhancementCritical concentrations in the dilution of oral self-microemulsifying drug delivery systems.Food protein-stabilized nanoemulsions as potential delivery systems for poorly water-soluble drugs: preparation, in vitro characterization, and pharmacokinetics in ratsSolid self-nanoemulsifying cyclosporin A pellets prepared by fluid-bed coating: preparation, characterization and in vitro redispersibility.Development of an enhanced formulation for delivering sustained release of buprenorphine hydrochloride.SEDDS of gliclazide: Preparation and characterization by in-vitro, ex-vivo and in-vivo techniques.In situ formation of nanocrystals from a self-microemulsifying drug delivery system to enhance oral bioavailability of fenofibrate.Lacidipine self-nanoemulsifying drug delivery system for the enhancement of oral bioavailability.Absolute oral bioavailability of fenofibric acid and choline fenofibrate in rats determined by ultra-performance liquid chromatography tandem mass spectrometry.Comparative study on solid self-nanoemulsifying drug delivery and solid dispersion system for enhanced solubility and bioavailability of ezetimibe.Combined use of phospholipid complexes and self-emulsifying microemulsions for improving the oral absorption of a BCS class IV compound, baicalin.Granulated colloidal silicon dioxide-based self-microemulsifying tablets, as a versatile approach in enhancement of solubility and therapeutic potential of anti-diabetic agent: formulation design and in vitro/in vivo evaluation.Development and characterization of a novel nanoemulsion drug-delivery system for potential application in oral delivery of protein drugs.Systematic development of self-emulsifying drug delivery systems of atorvastatin with improved bioavailability potential.In vitro and in vivo evaluation of a water-in-oil microemulsion system for enhanced peptide intestinal delivery.Development of self-nanoemulsifying drug delivery systems for the enhancement of solubility and oral bioavailability of fenofibrate, a poorly water-soluble drug.Self-microemulsifying drug delivery system for improved oral bioavailability of oleanolic acid: design and evaluation.Evaluation of Carbamazepine (CBZ) Supersaturatable Self-Microemulsifying (S-SMEDDS) Formulation In-vitro and In-vivo.Multiple nanoemulsion system for an oral combinational delivery of oxaliplatin and 5-fluorouracil: preparation and in vivo evaluation.New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs.A critical appraisal of microemulsions for drug delivery: part II.Application of Box-Behnken design in the preparation and optimization of fenofibrate-loaded self-microemulsifying drug delivery system (SMEDDS).Potential of novel drug delivery strategies for the treatment of hyperlipidemia.Self-Microemulsifying Drug Delivery Systems: An Attractive Strategy for Enhanced Therapeutic Profile.Self-emulsifying drug delivery systems as a tool to improve solubility and bioavailability of resveratrolPreparation and bioavailability assessment of SMEDDS containing valsartan.Design and evaluation of Lumefantrine - Oleic acid self nanoemulsifying ionic complex for enhanced dissolution.Solubility and bioavailability enhancement of poorly aqueous soluble atorvastatin: in vitro, ex vivo, and in vivo studies.Novel Solid Self-Nanoemulsifying Drug Delivery System (S-SNEDDS) for Oral Delivery of Olmesartan Medoxomil: Design, Formulation, Pharmacokinetic and Bioavailability Evaluation.The utility of self-emulsifying oil formulation to improve the poor solubility of the anti HIV drug CSIC.A comparison between use of spray and freeze drying techniques for preparation of solid self-microemulsifying formulation of valsartan and in vitro and in vivo evaluation.Rice germ oil as multifunctional excipient in preparation of self-microemulsifying drug delivery system (SMEDDS) of tacrolimus.The role of lipid-based nano delivery systems on oral bioavailability enhancement of fenofibrate, a BCS II drug: comparison with fast-release formulations.Self-microemulsifiyng suppository formulation of β-artemether.Product development studies on surface-adsorbed nanoemulsion of olmesartan medoxomil as a capsular dosage form.Permeability enhancing lipid-based co-solvent and SEDDS formulations of SQ641, an antimycobacterial agent.Enhanced transdermal permeability of piroxicam through novel nanoemulgel formulation.Development and characterization of dilutable self-microemulsifying premicroemulsion systems (SMEPMS) as templates for preparation of nanosized particulates.Characterisation of fenofibrate dissolution delivered by a self-microemulsifying drug-delivery system.
P2860
Q26801043-21C5AF00-0AB8-4686-BDD0-D22AE3E9D79CQ30406598-73AFC9AA-9109-4928-A085-30694F27C7FEQ33514056-25B0C2EC-212F-406E-91D2-822E00B8E907Q34730028-183B68D1-C53B-4A7C-A24D-A5B16D4AABF1Q34956330-2D4628C3-4612-4105-9D5A-09BD5490F70AQ34957716-FC0DD49B-ABC1-4ECF-A148-B35EB80E134BQ35232731-492E1428-809E-44F9-956A-16B0B4169B08Q35488199-1D496DE1-9615-4B16-9AF0-C818ED643CE1Q35771256-2351E3D0-BDCF-4E4A-AEFC-65286E52290CQ36122865-DB2FC3F4-EBC0-4BDF-90D6-262F2C529BF9Q36137372-ACC99519-8726-4C35-B9AD-6F73056BB558Q36237489-7E4A00D2-D019-413A-947F-89C832D0B17EQ36301891-DB097464-4892-4CB3-81AB-DD937CAD5071Q36359394-F45F9C66-E47D-4441-B570-6AA5C5D1632FQ36482118-D84F1E4F-E8A8-4DD6-AA56-0998C21496D2Q36502414-E92EC932-9D4D-4F3D-A9D2-ACD9E934F639Q37021478-A54EFEAD-CE02-4FBB-9A67-D61DE1CF48B4Q37095744-F6EF3ECF-C9AC-400B-841B-89F72F8E0281Q37268140-EC034185-E128-42BB-85A7-6154F7081B9EQ37474599-21E39139-0D0A-463D-9A2D-CDF52B9236F6Q37805592-940ED654-B755-45EF-93A4-E87F3D921769Q38171567-38B25B87-F336-4FFF-85C8-63FCC08A6FC8Q38448902-1CC37479-991A-4B81-B52B-A2367F371D23Q38794030-045363C9-2558-477C-BAA5-E9B5942F19DBQ38887547-39EADEEC-4C0C-4548-A08E-9FB11FDDBB0BQ38918022-5BA813BB-C2A2-47A1-92E3-243A6546051EQ39922643-91F55043-C66C-42B8-B236-67F89CC5CC7BQ40098763-CCFE1D42-9D3B-42A6-BB45-093007B376E1Q40960200-2D220A51-5741-4E70-9469-8FDD528927E7Q41201676-FD5559F2-0EDA-460A-9588-1F2C167AE695Q41832847-2A5AF1CC-AC45-4E56-B9F8-64BC90178B69Q41845360-50ACA980-B1BD-410D-A047-859A690358E1Q41855748-A53E61C2-CF6C-4C26-B80D-389D23DB4E22Q41889403-D97A285C-62E5-4AB3-AF35-DB8CF03997F0Q41939800-A99297CA-F3C5-4E5F-BB0C-1769CD0651A4Q41988178-3EAFA48B-9B42-4F95-BD14-1C6657EA4311Q42209752-0840A8E2-5DB5-43D6-BC64-5BE3EC61FB84Q42583117-070549B4-1EBA-4FA8-AF69-5D8A690AEF7BQ42628985-694A6660-EB5C-40EE-A87B-EDBCD270A9D1Q42835474-3EB73A99-6B25-4FBA-86DC-12911736E648
P2860
Preparation and in vivo evaluation of SMEDDS (self-microemulsifying drug delivery system) containing fenofibrate
description
2007 nî lūn-bûn
@nan
2007 թուականին հրատարակուած գիտական յօդուած
@hyw
2007 թվականին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Preparation and in vivo evalua ...... system) containing fenofibrate
@ast
Preparation and in vivo evalua ...... system) containing fenofibrate
@en
Preparation and in vivo evalua ...... system) containing fenofibrate
@nl
type
label
Preparation and in vivo evalua ...... system) containing fenofibrate
@ast
Preparation and in vivo evalua ...... system) containing fenofibrate
@en
Preparation and in vivo evalua ...... system) containing fenofibrate
@nl
prefLabel
Preparation and in vivo evalua ...... system) containing fenofibrate
@ast
Preparation and in vivo evalua ...... system) containing fenofibrate
@en
Preparation and in vivo evalua ...... system) containing fenofibrate
@nl
P2860
P3181
P356
P1433
P1476
Preparation and in vivo evalua ...... system) containing fenofibrate
@en
P2093
Pradeep R Vavia
P2860
P2888
P304
P3181
P356
10.1208/AAPSJ0903041
P407
P577
2007-10-26T00:00:00Z
P5875
P6179
1049303751